Having trouble viewing this email? View in your browser.

19 March 2019

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


Registration for ECCMID 2019

ECCMID is approaching soon in Amsterdam!

Registrations are available at a reduced rate for ESCMID members on the official website.

Make sure you use our official website to book your hotels to get the best rates.

› Read more

TAE Trainees Day 2019 – Register Now!

Registration for TAE Trainees Day 2019 at ECCMID has been opened! As in previous years, we kindly ask you to sign up for the table of your preferred expert, and we will try to accommodate your preference. Your chosen expert’s table may soon fill up, so we recommend to register now!

We are now offering fifteen round tables which will be hosted in total by fifteen renowned experts with different profiles in the fields of clinical microbiology and infectious diseases. Please find more information, the moderators’ CVs and registration for the TAE Day here.

› Read more

ESCMID Postgraduate Course - Zagreb, Croatia

The ESCMID study group for forensic and post-mortem microbiology (ESGFOR) is delighted to announce the ESGFOR postgraduate course ‘Challenges in the diagnosis of life-threatening infections’, which will take place on October 10-12, 2019 in Zagreb, Croatia.

In this event, 18 European renowned faculty members involved in the clinical, molecular and forensic diagnosis of life-threatening infections caused by classical and emerging pathogens will share their experience through lectures and a practical approach with case discussions.

See this course, and others, on the ESCMID website.

› Read more

CMI Highlight: Monomicrobial Klebsiella pneumoniae necrotizing fasciitis: an emerging life-threatening entity

Rahim et. Al reported on a recent surge in monomicrobial Necrotising Fasciitis (NF) caused by Klebsiella pneumoniae (KP-NF).

KP-NF predominates in East Asia with the majority of cases reported from Taiwan alone. Reports from the Western hemisphere are also gradually rising.

KP-NF with its virulent course and high mortality, is an emerging life threat. Clinicians must be aware of its key features. Further comprehensive studies are needed for better insights into the spectrum of this fatal infection.

› Read more

Guideline Highlight: Public Consultation Phase on the draft version of the "ATS/ESCMID/ERS/IDSA Guidelines on Treatment of NTM"

The American Thoracic Society (ATS), European Respiratory Society (ERS), European Society
for Clinical Microbiology and Infectious Diseases (ESCMID), and Infectious Diseases Society of
America (IDSA) jointly sponsored the development of this Guideline to update the treatment recommendations for nontuberculous mycobacterial (NTM) pulmonary disease in adults.

This guideline focuses on pulmonary disease in adults (without cystic fibrosis or HIV infection) caused by the most common NTM pathogens comprising Mycobacterium avium complex (MAC), M. kansasii and M. xenopi among the slowly growing NTM and M. abscessus among the rapidly growing NTM. Twenty-two PICO questions and associated recommendations are included in the guideline.
The recommendations were developed based on the evidence.
Recommendations for the treatment of other NTM pulmonary pathogens that were not addressed
through the GRADE process are presented later in the document.

Those of you wishing to comment on the manuscript may write to the ESCMID Publications and Medical Guidelines Manager to request the (confidential) draft of the manuscript along with the comments form for listing feedback.
We are happy to receive your feedback and comments on the manuscript until 8th April 2019.

Please be aware that your comments and the authors’ responses to the comments will be made available online once the guideline is published.”

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.